AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Dec 13, 2021
30442_dirs_2021-12-13_1daa6f63-9eef-44c3-8349-84d2eff743ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-12-09
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-09 | Common Stock | S | 14994 | $212.13 | Disposed | 5758539 | Direct |
| 2021-12-10 | Common Stock | S | 309 | $210.20 | Disposed | 5758230 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $213.455. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $210.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.